Skip to search boxSkip to navigationSkip to main content

Large-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures

  • Thomas R. Austin
    ,
  • Howard A. Fink
    ,
  • Diana I. Jalal
    ,
  • Anna E. Törnqvist
    ,
  • Petra Buzkova
    ,
  • Joshua I. Barzilay
*Corresponding author for this work
  • University of Washington
    ,
  • VA Medical Center
    ,
  • University of Iowa
    ,
  • Department of Veterans Affairs
    ,
  • University of Gothenburg
    ,
  • Kaiser Permanente
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Hip fractures are associated with significant disability, high cost, and mortality. However, the exact biological mechanisms underlying susceptibility to hip fractures remain incompletely understood. In an exploratory search of the underlying biology as reflected through the circulating proteome, we performed a comprehensive Circulating Proteome Association Study (CPAS) meta-analysis for incident hip fractures. Analyses included 6430 subjects from two prospective cohort studies (Cardiovascular Health Study and Trøndelag Health Study) with circulating proteomics data (aptamer-based 5 K SomaScan version 4.0 assay; 4979 aptamers). Associations between circulating protein levels and incident hip fractures were estimated for each cohort using age and sex-adjusted Cox regression models. Participants experienced 643 incident hip fractures. Compared with the individual studies, inverse-variance weighted meta-analyses yielded more statistically significant associations, identifying 23 aptamers associated with incident hip fractures (conservative Bonferroni correction 0.05/4979, P < 1.0 × 10<sup>−5</sup>). The aptamers most strongly associated with hip fracture risk corresponded to two proteins of the growth hormone/insulin growth factor system (GHR and IGFBP2), as well as GDF15 and EGFR. High levels of several inflammation-related proteins (CD14, CXCL12, MMP12, ITIH3) were also associated with increased hip fracture risk. Ingenuity pathway analysis identified reduced LXR/RXR activation and increased acute phase response signaling to be overrepresented among those proteins associated with increased hip fracture risk. These analyses identified several circulating proteins and pathways consistently associated with incident hip fractures. These findings underscore the usefulness of the meta-analytic approach for comprehensive CPAS in a similar manner as has previously been observed for large-scale human genetic studies. Future studies should investigate the underlying biology of these potential novel drug targets.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 139-149 (11 pages)

Journal (Volume, Issue Number)

Journal of Bone and Mineral Research (Volume 39, Issue 2)

Publication milestones

  • Published - 02/2024

Publication status

Published - 02/2024

ISSN

0884-0431

Publication IDs

  • Scopus: 85192408818
  • PubMed: 38477735

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.04
Fractional count
26
Fractional count
0.96
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
26
Mentions
1
Citation count
14

Funding Details

The present study was supported by funding from the Swedish Research Council (2020-01392, CO); the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-720331 and ALFGBG-965235, CO); the Lundberg Foundation (LU2021-0096, CO); the Novo Nordisk Foundation (NNF 190C0055250, CO); and the Knut and Alice Wallenberg Foundation (KAW 2015.0317, CO). This research was also supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, and grants U01HL080295, U01HL130114, and R01HL144483 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). The funding sources had no role in the study design, data collection, data analysis, data interpretation, writing of the paper, or in the decision to submit the paper for publication.
FundersFunding numbers
NHLBI
-
NIA
-
NINDS
R01AG023629
NNF
NNF 190C0055250
Knut och Alice Wallenbergs Stiftelse
75N92021D00006, HHSN268200800007C, KAW 2015.0317, N01HC55222, N01HC85081, U01HL080295, N01HC85082, HHSN268201800001C, N01HC85080, HHSN268201200036C, N01HC85086, R01HL144483, N01HC85083, N01HC85079, U01HL130114
Swedish Federal Government
ALFGBG-720331, ALFGBG-965235
Lars Erik Lundbergs Stiftelse för Forskning och Utbildning
LU2021-0096
VR
2020-01392